Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.
Press releases published on April 23, 2025
2025 Massachusetts Prostate Cancer Symposium (virtual) - The latest in Prostate Cancer Diagnosis, Treatment, & Research
EIN Presswire
·
April 23, 2025
Incidence rate for prostate cancer has been increasing since 2014 at a rate of 3% per year overall BOSTON, MA, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- The Massachusetts Prostate Cancer Coalition (MPCC) will bring together today’s leading and …
National Core Indicators® Releases New Report on Aging and Disability Workforce
EIN Presswire
·
April 23, 2025
Report Reveals Promising Trends in Aging and Disability Direct Service Workforce CAMBRIDGE, MA, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- National Core Indicators—Aging …
Compass Furnished Apartments Releases 2024 Compassion Report
EIN Presswire
·
April 23, 2025
Highlighting purpose-driven impact across housing, sustainability, and community support QUINCY, MA, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Compass Furnished Apartments is proud to announce the release of its Annual Compassion Report, which …
ATS Launches High-Performance Heat Sinks for NVIDIA Jetson Orin™ NX Modules Operating in Super Mode
EIN Presswire
·
April 23, 2025
Advanced Thermal Solutions, Inc. (ATS) has launched an active heat sink series engineered for cooling NVIDIA Jetson Orin™ NX modules operating in Super Mode. NORWOOD, MA, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Advanced Thermal Solutions, …
Heranova Lifesciences Selected to Present at Six Conferences in 2025
EIN Presswire
·
April 23, 2025
Company Expands 2025 Conference Participation and Speaking Engagements BOSTON, MA, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Heranova Lifesciences Inc., a women’s health leader in advancing non-invasive diagnostics and reproductive health …
ProNexus and PRC Announce Strategic Collaboration to Strengthen Healthcare Advisory with Research & AI Analytics
EIN Presswire
·
April 23, 2025
ProNexus clients gain access to research solutions, AI-driven insights, and co-branded resources to improve patient care and operational performance. MARBLEHEAD, MA, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- ProNexus Advisory is pleased to …
Nantucket Wine & Food Festival Announces Star-Studded Chef Lineup for 2025
EIN Presswire
·
April 23, 2025
NANTUCKET, MA, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- The Nantucket Wine …
Five Years Strong: Better Day Nonprofit Enhances Dementia Care Model for Metrowest
EIN Presswire
·
April 23, 2025
Finding Joy in the Journey MARLBOROUGH, MA, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Better Day Adult Social Day Program (Better Day) is a hidden gem tucked away in a quiet residential neighborhood by Fort Meadow Reservoir, announces enhanced …
Xilio Therapeutics to Present Updated Phase 2 Data for Vilastobart, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Combination with Atezolizumab in Patients with Microsatellite Stable Colorectal Cancer at the 2025 ASCO Annual Meeting
GlobeNewswire
·
April 23, 2025
WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced plans to …
Brookline Bancorp Announces First Quarter Results
GlobeNewswire
·
April 23, 2025
Net Income of $19.1 million, EPS of $0.21 Operating Earnings of $20.0 million, Operating EPS of $0.22 Quarterly Dividend of $0.135 BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Brookline Bancorp, Inc. (NASDAQ: BRKL) (the “Company”) today announced net income …
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 23, 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued inducement awards …
Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
GlobeNewswire
·
April 23, 2025
NEEDHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
Correction: ThermoFab Expands Capabilities with Purchase of Reaction Injection Molding (RIM) Equipment
GlobeNewswire
·
April 23, 2025
This correction replaces our previous press release from 4/22/2025 SHIRLEY, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- ThermoFab, a trusted leader in thermoforming and injection molding heavy gauge plastic enclosures and single use components for medical …
ReversingLabs Named in 2025 Gartner® Market Guide for Software Supply Chain Security
GlobeNewswire
·
April 23, 2025
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- ReversingLabs (RL), the trusted name in file and software security, today announced it has been recognized as a Representative Vendor in the 2025 Gartner® Market Guide for Software Supply Chain Security …
Artax Biopharma to present Phase 2a data on Nck modulator AX-158, establishing novel mechanism of action in autoimmune disease at the 2025 SID Annual Meeting
GlobeNewswire
·
April 23, 2025
Late breaker abstract presentation to showcase clinical validation of first-in-class oral small molecule AX-158 in cohort of patients with psoriasis Full dataset to expand on previously announced topline results, reinforcing the potential of Nck modulation …
Aqua Leisure Launches SWIMBUDDY, the First-of-its-Kind Plush Toy for Water Play
GlobeNewswire
·
April 23, 2025
STOUGHTON, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Aqua Leisure, a leading innovator and manufacturer of pool floats, water toys and swim gear, has launched a plush toy made for play in water called Swimbuddy. Swimbuddy sparks imaginative play in and out …
Cullinan Therapeutics to Present Results from REZILIENT1, a Phase 1/2 Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy, at ASCO 2025
GlobeNewswire
·
April 23, 2025
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that results from the REZILIENT1 study of zipalertinib …
Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting
GlobeNewswire
·
April 23, 2025
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of …
Bicara Therapeutics to Present Updated Data from Ongoing Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
April 23, 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that updated data from …
Devo Announces Partnership with Detecteam to Automate Detection Engineering
GlobeNewswire
·
April 23, 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Devo Technology, the security data analytics company, today announced its strategic technical partnership with Detecteam, the attack simulation and detection lifecycle management company, to address critical …